Search Results - "Shirokova, M. N."

Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study by Potapenko, V. G., Baumert, E. V., Bobrova, A. A., Vashchenkov, R. V., Dorofeeva, N. V., Kaplanov, K. D., Karyagina, E. V., Levanov, A. N., Luchinin, A. S., Moiseev, S. I., Novitskii, A. V., Nizamutdinova, A. S., Pirogova, О. V., Povzun, S. A., Platonov, М. V., Porunova, V. V., Ptashnikov, D. А., Ryabchikova, V. V., Simeniv, S. Ya, Skorokhod, I. А., Ukrainchenko, Е. А., Chaginskaya, D. А., Shelekhova, T. V., Shirokova, M. N., Shutylev, A. A., Medvedeva, N. V.

“…Background . The treatment options for patients with multiple myeloma who refractory to previous bortezomib and lenalidomide therapy are limited. Pomalidomide…”
Get full text

The regional register of multiple myeloma: significance in the era of new drugs by Kaplanov, K.D., Shirokova, M.N.

“…Introduction. Trend of improving life expectancy of patients with multiple myeloma (MM) is observed from the second half of the 2000s. The changes occur in the…”
Get full text